Manchester Cancer Research Centre shared a post on LinkedIn:
“A Landmark Collaboration in Cancer Genomics.
A team of scientists from The University of Manchester and The Institute of Cancer Research have, for the first time, decoded the full range of mutations that drive tumor growth, which could help revolutionize how we detect, understand, and treat cancer.
The team forensically examined the genetic make-up of tumors in 16 different cancers. Their findings, which have been published in Nature Genetics, are the culmination of six years’ of research and could significantly increase the number of cancer patients eligible for targeted and immune-based treatments.
This landmark study was co-led by Professor David Wedge at the Manchester Cancer Research Centre and Professor Richard Houlson from The Institute of Cancer Research, London. It used whole-genome sequencing data from nearly 11,000 NHS patients with cancer, and is part of Genomics England’s 100,000 Genomes Project, which is the largest single genomics study for cancer ever to be undertaken worldwide.”
Read more about this research.”
Other articles about Manchester Cancer Research Centre on OncoDaily.